Credit Suisse AG decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 30.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 336,784 shares of the company’s stock after selling 144,581 shares during the period. Credit Suisse AG owned about 0.40% of HealthEquity worth $19,773,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Quadrant Capital Group LLC increased its holdings in HealthEquity by 62.7% in the 4th quarter. Quadrant Capital Group LLC now owns 540 shares of the company’s stock worth $33,000 after buying an additional 208 shares in the last quarter. Assetmark Inc. lifted its position in HealthEquity by 24.5% during the first quarter. Assetmark Inc. now owns 940 shares of the company’s stock valued at $55,000 after purchasing an additional 185 shares during the period. Arcadia Investment Management Corp MI purchased a new stake in HealthEquity in the fourth quarter worth approximately $65,000. Captrust Financial Advisors grew its position in HealthEquity by 92.5% in the 1st quarter. Captrust Financial Advisors now owns 1,176 shares of the company’s stock worth $79,000 after purchasing an additional 565 shares during the period. Finally, Bessemer Group Inc. raised its stake in HealthEquity by 4,772.2% during the 1st quarter. Bessemer Group Inc. now owns 2,631 shares of the company’s stock valued at $154,000 after buying an additional 2,577 shares during the last quarter. Hedge funds and other institutional investors own 98.80% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently commented on HQY shares. StockNews.com initiated coverage on HealthEquity in a report on Thursday, August 17th. They issued a “hold” rating for the company. Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $69.00 to $71.00 in a research report on Wednesday, June 7th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus price target of $82.33.
HealthEquity Stock Down 0.8 %
HQY stock opened at $67.11 on Thursday. The business’s 50-day moving average price is $64.80 and its 200-day moving average price is $61.11. The stock has a market cap of $5.74 billion, a P/E ratio of -671.10, a PEG ratio of 2.66 and a beta of 0.82. HealthEquity, Inc. has a twelve month low of $48.86 and a twelve month high of $79.20. The company has a quick ratio of 4.00, a current ratio of 4.00 and a debt-to-equity ratio of 0.45.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its quarterly earnings results on Monday, June 5th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.09. The business had revenue of $244.43 million for the quarter, compared to the consensus estimate of $239.85 million. HealthEquity had a negative net margin of 0.93% and a positive return on equity of 4.30%. On average, equities research analysts forecast that HealthEquity, Inc. will post 1.2 EPS for the current year.
Insider Buying and Selling
In other news, CEO Jon Kessler sold 19,588 shares of the business’s stock in a transaction dated Monday, June 26th. The stock was sold at an average price of $60.12, for a total value of $1,177,630.56. Following the transaction, the chief executive officer now directly owns 6,129 shares in the company, valued at $368,475.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Elimelech Rosner sold 10,156 shares of the firm’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $64.29, for a total transaction of $652,929.24. Following the completion of the transaction, the executive vice president now directly owns 70,334 shares of the company’s stock, valued at $4,521,772.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon Kessler sold 19,588 shares of the business’s stock in a transaction on Monday, June 26th. The stock was sold at an average price of $60.12, for a total transaction of $1,177,630.56. Following the completion of the sale, the chief executive officer now owns 6,129 shares in the company, valued at approximately $368,475.48. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by insiders.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- Dividend Payout Ratio Calculator
- Bear Market vs Recession: What Are the Differences?
- How to Invest in Grocery Stores
- 7 Best AI Mutual Funds (and ETFs) to Sweep the AI Craze
- Stock Dividend Cuts Happen Are You Ready?
- Auto Parts Stocks Shift Gears: Which is the Right One to Buy?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
